Erythrocyte indexes, iron metabolism, and hyperhomocysteinemia in adults with cyanotic congenital cardiac disease
(8)
Soluble transferrin receptor for the evaluation of erythropoiesis and iron status
Clin Chimica Acta
(2003)- et al.
Adults with cyanotic congenital heart disease: hematologic management
Ann Intern Med
(1988) Complications in chronic cyanotic heart disease
- et al.
Measured versus calculated iron binding capacity in plasma of newborns
Ann Clin Biochem
(1995)
There are more references available in the full text version of this article.
Cited by (56)
2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019, Journal of the American College of CardiologySubclinical atherosclerosis in patients with cyanotic congenital heart disease
2019, International Journal of CardiologyGeneral measures and supportive therapy for pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018
2018, International Journal of CardiologyUse of intravenous iron in cyanotic patients with congenital heart disease and/or pulmonary hypertension
2018, International Journal of CardiologyEisenmenger syndrome
2018, Diagnosis and Management of Adult Congenital Heart Disease: Third Edition
This study was supported by the German Association for Children With Congenital Cardiac Disorders (“Herzkind e.V.), Braunschweig, Germany.
Copyright © 2004 Excerpta Medica Inc. All rights reserved.